Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,500 35 40 35 40 B-lower_bound
/ 40 41 40 41 I-lower_bound
mcL 41 44 41 44 I-lower_bound
except 45 51 45 51 O
in 52 54 52 54 O
cases 55 60 55 60 O
of 61 63 61 63 O
marrow 64 70 64 70 O
infiltration 71 83 71 83 O
by 84 86 84 86 O
lymphoma 87 95 87 95 B-cancer

Aspartate 0 9 96 105 B-clinical_variable
aminotransferase 10 26 106 122 I-clinical_variable
( 27 28 123 124 I-clinical_variable
AST 28 31 124 127 I-clinical_variable
) 31 32 127 128 I-clinical_variable
( 33 34 129 130 O
serum 34 39 130 135 B-clinical_variable
glutamic 40 48 136 144 I-clinical_variable
oxaloacetic 49 60 145 156 I-clinical_variable
transaminase 61 73 157 169 I-clinical_variable
[ 74 75 170 171 I-clinical_variable
SGOT])/alanine 75 89 171 185 I-clinical_variable
aminotransferase 90 106 186 202 I-clinical_variable
( 107 108 203 204 I-clinical_variable
ALT 108 111 204 207 I-clinical_variable
) 111 112 207 208 I-clinical_variable
( 113 114 209 210 O
serum 114 119 210 215 B-clinical_variable
glutamate 120 129 216 225 I-clinical_variable
pyruvate 130 138 226 234 I-clinical_variable
transaminase 139 151 235 247 I-clinical_variable
[ 152 153 248 249 I-clinical_variable
SGPT 153 157 249 253 I-clinical_variable
] 157 158 253 254 I-clinical_variable
) 158 159 254 255 O
= 160 161 256 257 O
< 161 162 257 258 O
2.5 163 166 259 262 B-upper_bound
X 167 168 263 264 I-upper_bound
ULN 169 172 265 268 I-upper_bound
or 173 175 269 271 O
= 176 177 272 273 O
< 177 178 273 274 O
5 179 180 275 276 O
X 181 182 277 278 O
ULN 183 186 279 282 O
for 187 190 283 286 O
subjects 191 199 287 295 O
with 200 204 296 300 O
liver 205 210 301 306 B-cancer
metastases 211 221 307 317 I-cancer

Composite 0 9 318 327 O
lymphomas 10 19 328 337 B-cancer
, 19 20 337 338 O
which 21 26 339 344 O
include 27 34 345 352 O
both 35 39 353 357 O
diffuse 40 47 358 365 O
DLBCL 48 53 366 371 B-cancer
and 54 57 372 375 O
another 58 65 376 383 O
histology 66 75 384 393 O
( 76 77 394 395 O
most 77 81 395 399 O
commonly 82 90 400 408 O
follicular 91 101 409 419 B-cancer
lymphoma 102 110 420 428 I-cancer
) 110 111 428 429 O
in 112 114 430 432 O
the 115 118 433 436 O
same 119 123 437 441 O
lymph 124 129 442 447 O
node 130 134 448 452 O

Discordant 0 10 453 463 O
presentations 11 24 464 477 O
, 24 25 477 478 O
such 26 30 479 483 O
as 31 33 484 486 O
DLBCL 34 39 487 492 B-cancer
in 40 42 493 495 O
a 43 44 496 497 O
lymph 45 50 498 503 O
node 51 55 504 508 O
and 56 59 509 512 O
low 60 63 513 516 O
- 63 64 516 517 O
grade 64 69 517 522 O
lymphoma 70 78 523 531 B-cancer
such 79 83 532 536 O
as 84 86 537 539 O
follicular 87 97 540 550 B-cancer
lymphoma 98 106 551 559 I-cancer
in 107 109 560 562 O
the 110 113 563 566 O
bone 114 118 567 571 O
marrow 119 125 572 578 O

Female 0 6 579 585 B-gender
subject 7 14 586 593 I-gender
of 15 17 594 596 O
childbearing 18 30 597 609 O
potential 31 40 610 619 O
should 41 47 620 626 O
have 48 52 627 631 O
a 53 54 632 633 O
negative 55 63 634 642 B-pregnancy
urine 64 69 643 648 I-pregnancy
or 70 72 649 651 I-pregnancy
serum 73 78 652 657 I-pregnancy
pregnancy 79 88 658 667 I-pregnancy
within 89 95 668 674 O
72 96 98 675 677 B-upper_bound
hours 99 104 678 683 I-upper_bound
prior 105 110 684 689 I-upper_bound
to 111 113 690 692 O
receiving 114 123 693 702 O
the 124 127 703 706 O
first 128 133 707 712 O
dose 134 138 713 717 O
of 139 141 718 720 O
study 142 147 721 726 O
medication 148 158 727 737 B-treatment

Female 0 6 738 744 B-gender
subjects 7 15 745 753 I-gender
of 16 18 754 756 O
childbearing 19 31 757 769 O
potential 32 41 770 779 O
should 42 48 780 786 O
be 49 51 787 789 O
willing 52 59 790 797 O
to 60 62 798 800 O
use 63 66 801 804 B-contraception_consent
2 67 68 805 806 I-contraception_consent
methods 69 76 807 814 I-contraception_consent
of 77 79 815 817 I-contraception_consent
birth 80 85 818 823 I-contraception_consent
control 86 93 824 831 I-contraception_consent
or 94 96 832 834 O
be 97 99 835 837 O
surgically 100 110 838 848 B-contraception_consent
sterile 111 118 849 856 I-contraception_consent
, 118 119 856 857 O
or 120 122 858 860 O
abstain 123 130 861 868 B-contraception_consent
from 131 135 869 873 I-contraception_consent
heterosexual 136 148 874 886 I-contraception_consent
activity 149 157 887 895 I-contraception_consent
for 158 161 896 899 I-contraception_consent
the 162 165 900 903 I-contraception_consent
course 166 172 904 910 I-contraception_consent
of 173 175 911 913 O
the 176 179 914 917 O
study 180 185 918 923 O
through 186 193 924 931 O
120 194 197 932 935 B-upper_bound
days 198 202 936 940 I-upper_bound
after 203 208 941 946 I-upper_bound
the 209 212 947 950 O
last 213 217 951 955 O
dose 218 222 956 960 O
of 223 225 961 963 O
study 226 231 964 969 O
medication 232 242 970 980 B-treatment

Has 0 3 981 984 O
a 4 5 985 986 O
diagnosis 6 15 987 996 O
of 16 18 997 999 O
immunodeficiency 19 35 1000 1016 B-chronic_disease
or 36 38 1017 1019 O
is 39 41 1020 1022 O
receiving 42 51 1023 1032 O
systemic 52 60 1033 1041 B-treatment
steroid 61 68 1042 1049 I-treatment
therapy 69 76 1050 1057 I-treatment
or 77 79 1058 1060 O
any 80 83 1061 1064 O
other 84 89 1065 1070 O
form 90 94 1071 1075 O
of 95 97 1076 1078 O
immunosuppressive 98 115 1079 1096 B-treatment
therapy 116 123 1097 1104 I-treatment
within 124 130 1105 1111 O
7 131 132 1112 1113 B-upper_bound
days 133 137 1114 1118 I-upper_bound
prior 138 143 1119 1124 I-upper_bound
to 144 146 1125 1127 O
the 147 150 1128 1131 O
first 151 156 1132 1137 O
dose 157 161 1138 1142 O
of 162 164 1143 1145 O
trial 165 170 1146 1151 O
treatment 171 180 1152 1161 B-treatment

Has 0 3 1162 1165 O
a 4 5 1166 1167 O
history 6 13 1168 1175 O
or 14 16 1176 1178 O
current 17 24 1179 1186 O
evidence 25 33 1187 1195 O
of 34 36 1196 1198 O
any 37 40 1199 1202 O
condition 41 50 1203 1212 O
, 50 51 1212 1213 O
therapy 52 59 1214 1221 B-treatment
, 59 60 1221 1222 O
or 61 63 1223 1225 O
laboratory 64 74 1226 1236 O
abnormality 75 86 1237 1248 O
that 87 91 1249 1253 O
might 92 97 1254 1259 O
confound 98 106 1260 1268 O
the 107 110 1269 1272 O
results 111 118 1273 1280 O
of 119 121 1281 1283 O
the 122 125 1284 1287 O
trial 126 131 1288 1293 O
, 131 132 1293 1294 O
interfere 133 142 1295 1304 O
with 143 147 1305 1309 O
the 148 151 1310 1313 O
subject 152 159 1314 1321 O
's 159 161 1321 1323 O
participation 162 175 1324 1337 O
for 176 179 1338 1341 O
the 180 183 1342 1345 O
full 184 188 1346 1350 O
duration 189 197 1351 1359 O
of 198 200 1360 1362 O
the 201 204 1363 1366 O
trial 205 210 1367 1372 O
, 210 211 1372 1373 O
or 212 214 1374 1376 O
is 215 217 1377 1379 O
not 218 221 1380 1383 O
in 222 224 1384 1386 O
the 225 228 1387 1390 O
best 229 233 1391 1395 O
interest 234 242 1396 1404 O
of 243 245 1405 1407 O
the 246 249 1408 1411 O
subject 250 257 1412 1419 O
to 258 260 1420 1422 O
participate 261 272 1423 1434 O
, 272 273 1434 1435 O
in 274 276 1436 1438 O
the 277 280 1439 1442 O
opinion 281 288 1443 1450 O
of 289 291 1451 1453 O
the 292 295 1454 1457 O
treating 296 304 1458 1466 O
investigator 305 317 1467 1479 O

Has 0 3 1480 1483 O
a 4 5 1484 1485 O
known 6 11 1486 1491 O
additional 12 22 1492 1502 O
malignancy 23 33 1503 1513 B-cancer
that 34 38 1514 1518 O
is 39 41 1519 1521 O
progressing 42 53 1522 1533 O
or 54 56 1534 1536 O
requires 57 65 1537 1545 O
active 66 72 1546 1552 B-treatment
treatment 73 82 1553 1562 I-treatment

Has 0 3 1563 1566 O
a 4 5 1567 1568 O
known 6 11 1569 1574 O
history 12 19 1575 1582 O
of 20 22 1583 1585 O
human 23 28 1586 1591 B-chronic_disease
immunodeficiency 29 45 1592 1608 I-chronic_disease
virus 46 51 1609 1614 I-chronic_disease
( 52 53 1615 1616 I-chronic_disease
HIV 53 56 1616 1619 I-chronic_disease
) 56 57 1619 1620 I-chronic_disease
( 58 59 1621 1622 O
HIV 59 62 1622 1625 O
1/2 63 66 1626 1629 O
antibodies 67 77 1630 1640 O
) 77 78 1640 1641 O

Has 0 3 1642 1645 O
an 4 6 1646 1648 O
active 7 13 1649 1655 B-chronic_disease
infection 14 23 1656 1665 I-chronic_disease
requiring 24 33 1666 1675 O
intravenous 34 45 1676 1687 B-treatment
antibiotic 46 56 1688 1698 I-treatment
therapy 57 64 1699 1706 I-treatment

Has 0 3 1707 1710 O
history 4 11 1711 1718 O
of 12 14 1719 1721 O
non 15 18 1722 1725 O
- 18 19 1725 1726 O
infectious 19 29 1726 1736 O
pneumonitis 30 41 1737 1748 B-chronic_disease
that 42 46 1749 1753 O
required 47 55 1754 1762 O
steroids 56 64 1763 1771 B-treatment
or 65 67 1772 1774 O
current 68 75 1775 1782 O
pneumonitis 76 87 1783 1794 O

Has 0 3 1795 1798 O
known 4 9 1799 1804 O
active 10 16 1805 1811 O
central 17 24 1812 1819 B-cancer
nervous 25 32 1820 1827 I-cancer
system 33 39 1828 1834 I-cancer
( 40 41 1835 1836 I-cancer
CNS 41 44 1836 1839 I-cancer
) 44 45 1839 1840 I-cancer
metastases 46 56 1841 1851 I-cancer
and/or 57 63 1852 1858 O
carcinomatous 64 77 1859 1872 B-cancer
meningitis 78 88 1873 1883 I-cancer
; 88 89 1883 1884 O
subjects 90 98 1885 1893 O
with 99 103 1894 1898 O
previously 104 114 1899 1909 O
treated 115 122 1910 1917 O
brain 123 128 1918 1923 B-cancer
metastases 129 139 1924 1934 I-cancer
may 140 143 1935 1938 O
participate 144 155 1939 1950 O
provided 156 164 1951 1959 O
they 165 169 1960 1964 O
are 170 173 1965 1968 O
stable 174 180 1969 1975 O
( 181 182 1976 1977 O
without 182 189 1977 1984 O
evidence 190 198 1985 1993 O
of 199 201 1994 1996 O
progression 202 213 1997 2008 O
by 214 216 2009 2011 O
imaging 217 224 2012 2019 O
for 225 228 2020 2023 O
at 229 231 2024 2026 O
least 232 237 2027 2032 O
four 238 242 2033 2037 B-lower_bound
weeks 243 248 2038 2043 I-lower_bound
prior 249 254 2044 2049 I-lower_bound
to 255 257 2050 2052 O
the 258 261 2053 2056 O
first 262 267 2057 2062 O
dose 268 272 2063 2067 O
of 273 275 2068 2070 O
trial 276 281 2071 2076 B-treatment
treatment 282 291 2077 2086 I-treatment
and 292 295 2087 2090 O
any 296 299 2091 2094 O
neurologic 300 310 2095 2105 O
symptoms 311 319 2106 2114 O
have 320 324 2115 2119 O
returned 325 333 2120 2128 O
to 334 336 2129 2131 O
baseline 337 345 2132 2140 O
) 345 346 2140 2141 O
, 346 347 2141 2142 O
have 348 352 2143 2147 O
no 353 355 2148 2150 O
evidence 356 364 2151 2159 O
of 365 367 2160 2162 O
new 368 371 2163 2166 O
or 372 374 2167 2169 O
enlarging 375 384 2170 2179 O
brain 385 390 2180 2185 O
metastases 391 401 2186 2196 O
, 401 402 2196 2197 O
and 403 406 2198 2201 O
are 407 410 2202 2205 O
not 411 414 2206 2209 O
using 415 420 2210 2215 O
steroids 421 429 2216 2224 B-treatment

Has 0 3 2225 2228 O
known 4 9 2229 2234 O
active 10 16 2235 2241 B-chronic_disease
hepatitis 17 26 2242 2251 I-chronic_disease
B 27 28 2252 2253 I-chronic_disease
( 29 30 2254 2255 O
e.g. 30 34 2255 2259 O
, 34 35 2259 2260 O
hepatitis 36 45 2261 2270 O
B 46 47 2271 2272 O
virus 48 53 2273 2278 O
surface 54 61 2279 2286 O
protein 62 69 2287 2294 O
antigen 70 77 2295 2302 O
[ 78 79 2303 2304 O
HBsAg 79 84 2304 2309 O
] 84 85 2309 2310 O
reactive 86 94 2311 2319 O
or 95 97 2320 2322 O
hepatitis 98 107 2323 2332 O
B 108 109 2333 2334 O
virus 110 115 2335 2340 O
[ 116 117 2341 2342 O
HBV 117 120 2342 2345 O
] 120 121 2345 2346 O
deoxyribonucleic 122 138 2347 2363 O
acid 139 143 2364 2368 O
[ 144 145 2369 2370 O
DNA 145 148 2370 2373 O
] 148 149 2373 2374 O
detectable 150 160 2375 2385 O
) 160 161 2385 2386 O
or 162 164 2387 2389 O
hepatitis 165 174 2390 2399 B-chronic_disease
C 175 176 2400 2401 I-chronic_disease
( 177 178 2402 2403 O
e.g. 178 182 2403 2407 O
, 182 183 2407 2408 O
hepatitis 184 193 2409 2418 O
C 194 195 2419 2420 O
virus 196 201 2421 2426 O
[ 202 203 2427 2428 O
HCV 203 206 2428 2431 O
] 206 207 2431 2432 O
ribonucleic 208 219 2433 2444 O
acid 220 224 2445 2449 O
[ 225 226 2450 2451 O
RNA 226 229 2451 2454 O
] 229 230 2454 2455 O
[ 231 232 2456 2457 O
qualitative 232 243 2457 2468 O
] 243 244 2468 2469 O
is 245 247 2470 2472 O
detected 248 256 2473 2481 O
) 256 257 2481 2482 O

Has 0 3 2483 2486 O
known 4 9 2487 2492 O
psychiatric 10 21 2493 2504 B-chronic_disease
or 22 24 2505 2507 O
substance 25 34 2508 2517 B-chronic_disease
abuse 35 40 2518 2523 I-chronic_disease
disorders 41 50 2524 2533 I-chronic_disease
that 51 55 2534 2538 O
would 56 61 2539 2544 O
interfere 62 71 2545 2554 O
with 72 76 2555 2559 O
cooperation 77 88 2560 2571 O
with 89 93 2572 2576 O
the 94 97 2577 2580 O
requirements 98 110 2581 2593 O
of 111 113 2594 2596 O
the 114 117 2597 2600 O
trial 118 123 2601 2606 O

Has 0 3 2607 2610 O
received 4 12 2611 2619 O
a 13 14 2620 2621 O
live 15 19 2622 2626 B-treatment
vaccine 20 27 2627 2634 I-treatment
within 28 34 2635 2641 O
30 35 37 2642 2644 B-upper_bound
days 38 42 2645 2649 I-upper_bound
prior 43 48 2650 2655 I-upper_bound
to 49 51 2656 2658 O
the 52 55 2659 2662 O
first 56 61 2663 2668 O
dose 62 66 2669 2673 O
of 67 69 2674 2676 O
trial 70 75 2677 2682 B-treatment
treatment 76 85 2683 2692 I-treatment

Has 0 3 2693 2696 O
received 4 12 2697 2705 O
prior 13 18 2706 2711 B-treatment
therapy 19 26 2712 2719 I-treatment
with 27 31 2720 2724 I-treatment
an 32 34 2725 2727 I-treatment
anti 35 39 2728 2732 I-treatment
- 39 40 2732 2733 I-treatment
PD-1 40 44 2733 2737 I-treatment
, 44 45 2737 2738 O
anti 46 50 2739 2743 B-treatment
- 50 51 2743 2744 I-treatment
programmed 51 61 2744 2754 I-treatment
cell 62 66 2755 2759 I-treatment
death 67 72 2760 2765 I-treatment
ligand 73 79 2766 2772 I-treatment
1 80 81 2773 2774 I-treatment
( 82 83 2775 2776 I-treatment
PD 83 85 2776 2778 I-treatment
- 85 86 2778 2779 I-treatment
L1 86 88 2779 2781 I-treatment
) 88 89 2781 2782 I-treatment
, 89 90 2782 2783 O
anti 91 95 2784 2788 B-treatment
- 95 96 2788 2789 I-treatment
programmed 96 106 2789 2799 I-treatment
cell 107 111 2800 2804 I-treatment
death 112 117 2805 2810 I-treatment
ligand 118 124 2811 2817 I-treatment
2 125 126 2818 2819 I-treatment
( 127 128 2820 2821 I-treatment
PD 128 130 2821 2823 I-treatment
- 130 131 2823 2824 I-treatment
L2 131 133 2824 2826 I-treatment
) 133 134 2826 2827 I-treatment
, 134 135 2827 2828 O
anti 136 140 2829 2833 B-treatment
- 140 141 2833 2834 I-treatment
tumor 141 146 2834 2839 I-treatment
necrosis 147 155 2840 2848 I-treatment
factor 156 162 2849 2855 I-treatment
receptor 163 171 2856 2864 I-treatment
superfamily 172 183 2865 2876 I-treatment
, 183 184 2876 2877 O
member 185 191 2878 2884 O
9 192 193 2885 2886 O
( 194 195 2887 2888 O
CD137 195 200 2888 2893 B-treatment
) 200 201 2893 2894 O
, 201 202 2894 2895 O
or 203 205 2896 2898 O
anti 206 210 2899 2903 B-treatment
- 210 211 2903 2904 I-treatment
cytotoxic 211 220 2904 2913 I-treatment
T 221 222 2914 2915 I-treatment
- 222 223 2915 2916 I-treatment
lymphocyte 223 233 2916 2926 I-treatment
- 233 234 2926 2927 I-treatment
associated 234 244 2927 2937 I-treatment
antigen-4 245 254 2938 2947 I-treatment
( 255 256 2948 2949 I-treatment
CTLA-4 256 262 2949 2955 I-treatment
) 262 263 2955 2956 I-treatment
antibody 264 272 2957 2965 I-treatment
( 273 274 2966 2967 O
including 274 283 2967 2976 O
ipilimumab 284 294 2977 2987 B-treatment
or 295 297 2988 2990 O
any 298 301 2991 2994 O
other 302 307 2995 3000 O
antibody 308 316 3001 3009 O
or 317 319 3010 3012 O
drug 320 324 3013 3017 B-treatment
specifically 325 337 3018 3030 I-treatment
targeting 338 347 3031 3040 I-treatment
T 348 349 3041 3042 I-treatment
- 349 350 3042 3043 I-treatment
cell 350 354 3043 3047 I-treatment
co 355 357 3048 3050 I-treatment
- 357 358 3050 3051 I-treatment
stimulation 358 369 3051 3062 I-treatment
or 370 372 3063 3065 O
checkpoint 373 383 3066 3076 O
pathways 384 392 3077 3085 O
) 392 393 3085 3086 O

Have 0 4 3087 3091 O
a 5 6 3092 3093 O
performance 7 18 3094 3105 O
status 19 25 3106 3112 O
of 26 28 3113 3115 O
0 29 30 3116 3117 B-lower_bound
or 31 33 3118 3120 O
1 34 35 3121 3122 B-upper_bound
on 36 38 3123 3125 O
the 39 42 3126 3129 O
Eastern 43 50 3130 3137 B-clinical_variable
Cooperative 51 62 3138 3149 I-clinical_variable
Oncology 63 71 3150 3158 I-clinical_variable
Group 72 77 3159 3164 I-clinical_variable
( 78 79 3165 3166 I-clinical_variable
ECOG 79 83 3166 3170 I-clinical_variable
) 83 84 3170 3171 I-clinical_variable
performance 85 96 3172 3183 I-clinical_variable
scale 97 102 3184 3189 I-clinical_variable
( 103 104 3190 3191 I-clinical_variable
PS 104 106 3191 3193 I-clinical_variable
) 106 107 3193 3194 I-clinical_variable

Have 0 4 3195 3199 O
measurable 5 15 3200 3210 O
nodal 16 21 3211 3216 B-cancer
disease 22 29 3217 3224 I-cancer

International 0 13 3225 3238 B-clinical_variable
normalized 14 24 3239 3249 I-clinical_variable
ratio 25 30 3250 3255 I-clinical_variable
( 31 32 3256 3257 I-clinical_variable
INR 32 35 3257 3260 I-clinical_variable
) 35 36 3260 3261 I-clinical_variable
or 37 39 3262 3264 O
prothrombin 40 51 3265 3276 B-clinical_variable
time 52 56 3277 3281 I-clinical_variable
( 57 58 3282 3283 I-clinical_variable
PT 58 60 3283 3285 I-clinical_variable
) 60 61 3285 3286 I-clinical_variable
= 62 63 3287 3288 O
< 63 64 3288 3289 O
1.5 65 68 3290 3293 B-upper_bound
X 69 70 3294 3295 I-upper_bound
ULN 71 74 3296 3299 I-upper_bound
unless 75 81 3300 3306 O
subject 82 89 3307 3314 O
is 90 92 3315 3317 O
receiving 93 102 3318 3327 O
anticoagulant 103 116 3328 3341 B-treatment
therapy 117 124 3342 3349 I-treatment

Is 0 2 3350 3352 O
currently 3 12 3353 3362 O
participating 13 26 3363 3376 O
and 27 30 3377 3380 O
receiving 31 40 3381 3390 O
study 41 46 3391 3396 B-treatment
therapy 47 54 3397 3404 I-treatment
or 55 57 3405 3407 O
has 58 61 3408 3411 O
participated 62 74 3412 3424 O
in 75 77 3425 3427 O
a 78 79 3428 3429 O
study 80 85 3430 3435 O
of 86 88 3436 3438 O
an 89 91 3439 3441 O
investigational 92 107 3442 3457 B-treatment
agent 108 113 3458 3463 I-treatment
and 114 117 3464 3467 O
received 118 126 3468 3476 O
study 127 132 3477 3482 B-treatment
drug 133 137 3483 3487 I-treatment
or 138 140 3488 3490 O
using 141 146 3491 3496 O
an 147 149 3497 3499 O
investigation 150 163 3500 3513 B-treatment
device 164 170 3514 3520 I-treatment
within 171 177 3521 3527 O
4 178 179 3528 3529 B-upper_bound
weeks 180 185 3530 3535 I-upper_bound
of 186 188 3536 3538 O
the 189 192 3539 3542 O
first 193 198 3543 3548 O
dose 199 203 3549 3553 O
of 204 206 3554 3556 O
treatment 207 216 3557 3566 B-treatment

Male 0 4 3567 3571 B-gender
subjects 5 13 3572 3580 I-gender
should 14 20 3581 3587 O
agree 21 26 3588 3593 B-contraception_consent
to 27 29 3594 3596 I-contraception_consent
use 30 33 3597 3600 I-contraception_consent
an 34 36 3601 3603 I-contraception_consent
adequate 37 45 3604 3612 I-contraception_consent
method 46 52 3613 3619 I-contraception_consent
of 53 55 3620 3622 I-contraception_consent
barrier 56 63 3623 3630 I-contraception_consent
contraception 64 77 3631 3644 I-contraception_consent
starting 78 86 3645 3653 O
with 87 91 3654 3658 O
the 92 95 3659 3662 O
first 96 101 3663 3668 O
dose 102 106 3669 3673 O
of 107 109 3674 3676 O
study 110 115 3677 3682 B-treatment
therapy 116 123 3683 3690 I-treatment
through 124 131 3691 3698 O
120 132 135 3699 3702 B-upper_bound
days 136 140 3703 3707 I-upper_bound
after 141 146 3708 3713 I-upper_bound
the 147 150 3714 3717 O
last 151 155 3718 3722 O
dose 156 160 3723 3727 O
of 161 163 3728 3730 O
study 164 169 3731 3736 O
therapy 170 177 3737 3744 O

No 0 2 3745 3747 O
active 3 9 3748 3754 O
autoimmune 10 20 3755 3765 B-chronic_disease
disease 21 28 3766 3773 I-chronic_disease
that 29 33 3774 3778 O
has 34 37 3779 3782 O
required 38 46 3783 3791 O
systemic 47 55 3792 3800 B-treatment
treatment 56 65 3801 3810 I-treatment
in 66 68 3811 3813 O
past 69 73 3814 3818 B-upper_bound
2 74 75 3819 3820 I-upper_bound
years 76 81 3821 3826 I-upper_bound
( 82 83 3827 3828 O
i.e. 83 87 3828 3832 O
with 88 92 3833 3837 O
use 93 96 3838 3841 O
of 97 99 3842 3844 O
disease 100 107 3845 3852 B-treatment
modifying 108 117 3853 3862 I-treatment
agents 118 124 3863 3869 I-treatment
, 124 125 3869 3870 O
corticosteroids 126 141 3871 3886 B-treatment
or 142 144 3887 3889 O
immunosuppressive 145 162 3890 3907 B-treatment
drugs 163 168 3908 3913 I-treatment
) 168 169 3913 3914 O

Platelets 0 9 3915 3924 B-clinical_variable
> 10 11 3925 3926 O
= 11 12 3926 3927 O
100,000 13 20 3928 3935 B-lower_bound
/ 20 21 3935 3936 I-lower_bound
mcL 21 24 3936 3939 I-lower_bound
except 25 31 3940 3946 O
in 32 34 3947 3949 O
cases 35 40 3950 3955 O
of 41 43 3956 3958 O
marrow 44 50 3959 3965 O
infiltration 51 63 3966 3978 O
by 64 66 3979 3981 O
lymphoma 67 75 3982 3990 B-cancer

Previously 0 10 3991 4001 O
untreated 11 20 4002 4011 O
diffuse 21 28 4012 4019 B-cancer
large 29 34 4020 4025 I-cancer
B 35 36 4026 4027 I-cancer
- 36 37 4027 4028 I-cancer
cell 37 41 4028 4032 I-cancer
lymphoma 42 50 4033 4041 I-cancer
or 51 53 4042 4044 O
grade 54 59 4045 4050 B-cancer
3B 60 62 4051 4053 I-cancer
follicular 63 73 4054 4064 I-cancer
lymphoma 74 82 4065 4073 I-cancer
( 83 84 4074 4075 O
of 84 86 4075 4077 O
any 87 90 4078 4081 O
stage 91 96 4082 4087 O
) 96 97 4087 4088 O

Serum 0 5 4089 4094 B-clinical_variable
creatinine 6 16 4095 4105 I-clinical_variable
= 17 18 4106 4107 O
< 18 19 4107 4108 O
1.5 20 23 4109 4112 B-upper_bound
X 24 25 4113 4114 I-upper_bound
upper 26 31 4115 4120 I-upper_bound
limit 32 37 4121 4126 I-upper_bound
of 38 40 4127 4129 I-upper_bound
normal 41 47 4130 4136 I-upper_bound
( 48 49 4137 4138 I-upper_bound
ULN 49 52 4138 4141 I-upper_bound
) 52 53 4141 4142 I-upper_bound
OR 54 56 4143 4145 O
measured 57 65 4146 4154 O
or 66 68 4155 4157 O
calculated 69 79 4158 4168 B-clinical_variable
creatinine 80 90 4169 4179 I-clinical_variable
clearance 91 100 4180 4189 I-clinical_variable
> 101 102 4190 4191 O
= 102 103 4191 4192 O
60 104 106 4193 4195 B-lower_bound
ml 107 109 4196 4198 I-lower_bound
/ 109 110 4198 4199 I-lower_bound
min 110 113 4199 4202 I-lower_bound
for 114 117 4203 4206 O
subject 118 125 4207 4214 O
with 126 130 4215 4219 O
creatinine 131 141 4220 4230 B-clinical_variable
levels 142 148 4231 4237 I-clinical_variable
> 149 150 4238 4239 O
1.5 151 154 4240 4243 B-lower_bound
X 155 156 4244 4245 I-lower_bound
institutional 157 170 4246 4259 I-lower_bound
ULN 171 174 4260 4263 I-lower_bound
( 175 176 4264 4265 O
glomerular 176 186 4265 4275 B-clinical_variable
filtration 187 197 4276 4286 I-clinical_variable
rate 198 202 4287 4291 I-clinical_variable
[ 203 204 4292 4293 I-clinical_variable
GFR 204 207 4293 4296 I-clinical_variable
] 207 208 4296 4297 I-clinical_variable
can 209 212 4298 4301 O
also 213 217 4302 4306 O
be 218 220 4307 4309 O
used 221 225 4310 4314 O
in 226 228 4315 4317 O
place 229 234 4318 4323 O
of 235 237 4324 4326 O
creatinine 238 248 4327 4337 O
or 249 251 4338 4340 O
creatinine 252 262 4341 4351 B-clinical_variable
clearance 263 272 4352 4361 I-clinical_variable
[ 273 274 4362 4363 I-clinical_variable
CrCl 274 278 4363 4367 I-clinical_variable
] 278 279 4367 4368 I-clinical_variable
) 279 280 4368 4369 O

Serum 0 5 4370 4375 B-clinical_variable
total 6 11 4376 4381 I-clinical_variable
bilirubin 12 21 4382 4391 I-clinical_variable
= 22 23 4392 4393 O
< 23 24 4393 4394 O
1.5 25 28 4395 4398 B-upper_bound
X 29 30 4399 4400 I-upper_bound
ULN 31 34 4401 4404 I-upper_bound
OR 35 37 4405 4407 O
direct 38 44 4408 4414 B-clinical_variable
bilirubin 45 54 4415 4424 I-clinical_variable
= 55 56 4425 4426 O
< 56 57 4426 4427 O
ULN 58 61 4428 4431 O
for 62 65 4432 4435 O
subjects 66 74 4436 4444 O
with 75 79 4445 4449 O
total 80 85 4450 4455 B-clinical_variable
bilirubin 86 95 4456 4465 I-clinical_variable
levels 96 102 4466 4472 I-clinical_variable
> 103 104 4473 4474 O
1.5 105 108 4475 4478 B-lower_bound
ULN 109 112 4479 4482 I-lower_bound

Transformed 0 11 4483 4494 O
lymphoma 12 20 4495 4503 B-cancer
with 21 25 4504 4508 O
DLBCL 26 31 4509 4514 B-cancer
histology 32 41 4515 4524 O
, 41 42 4524 4525 O
as 43 45 4526 4528 O
long 46 50 4529 4533 O
as 51 53 4534 4536 O
the 54 57 4537 4540 O
patient 58 65 4541 4548 O
has 66 69 4549 4552 O
not 70 73 4553 4556 O
received 74 82 4557 4565 O
prior 83 88 4566 4571 B-treatment
therapy 89 96 4572 4579 I-treatment
for 97 100 4580 4583 O
lymphoma 101 109 4584 4592 O

as 0 2 4593 4595 O
long 3 7 4596 4600 O
as 8 10 4601 4603 O
PT 11 13 4604 4606 O
or 14 16 4607 4609 O
PTT 17 20 4610 4613 O
is 21 23 4614 4616 O
within 24 30 4617 4623 O
therapeutic 31 42 4624 4635 O
range 43 48 4636 4641 O
of 49 51 4642 4644 O
intended 52 60 4645 4653 O
use 61 64 4654 4657 O
of 65 67 4658 4660 O
anticoagulants 68 82 4661 4675 B-treatment
, 82 83 4675 4676 O
or 84 86 4677 4679 O
subject 87 94 4680 4687 O
is 95 97 4688 4690 O
shown 98 103 4691 4696 O
to 104 106 4697 4699 O
have 107 111 4700 4704 O
an 112 114 4705 4707 O
antiphospholipid 115 131 4708 4724 O
antibody 132 140 4725 4733 O
on 141 143 4734 4736 O
workup 144 150 4737 4743 O

as 0 2 4744 4746 O
long 3 7 4747 4751 O
as 8 10 4752 4754 O
PT 11 13 4755 4757 B-clinical_variable
or 14 16 4758 4760 O
partial 17 24 4761 4768 B-clinical_variable
thromboplastin 25 39 4769 4783 I-clinical_variable
time 40 44 4784 4788 I-clinical_variable
( 45 46 4789 4790 I-clinical_variable
PTT 46 49 4790 4793 I-clinical_variable
) 49 50 4793 4794 I-clinical_variable
is 51 53 4795 4797 O
within 54 60 4798 4804 O
therapeutic 61 72 4805 4816 O
range 73 78 4817 4822 O
of 79 81 4823 4825 O
intended 82 90 4826 4834 O
use 91 94 4835 4838 O
of 95 97 4839 4841 O
anticoagulants 98 112 4842 4856 B-treatment
; 112 113 4856 4857 O
activated 114 123 4858 4867 B-clinical_variable
partial 124 131 4868 4875 I-clinical_variable
thromboplastin 132 146 4876 4890 I-clinical_variable
time 147 151 4891 4895 I-clinical_variable
( 152 153 4896 4897 I-clinical_variable
aPTT 153 157 4897 4901 I-clinical_variable
) 157 158 4901 4902 I-clinical_variable
= 159 160 4903 4904 O
< 160 161 4904 4905 O
1.5 162 165 4906 4909 B-upper_bound
X 166 167 4910 4911 I-upper_bound
ULN 168 171 4912 4915 I-upper_bound
unless 172 178 4916 4922 O
subject 179 186 4923 4930 O
is 187 189 4931 4933 O
receiving 190 199 4934 4943 O
anticoagulant 200 213 4944 4957 B-treatment
therapy 214 221 4958 4965 I-treatment

basal 0 5 4966 4971 B-cancer
cell 6 10 4972 4976 I-cancer
carcinoma 11 20 4977 4986 I-cancer
of 21 23 4987 4989 I-cancer
the 24 27 4990 4993 I-cancer
skin 28 32 4994 4998 I-cancer
, 32 33 4998 4999 O
squamous 34 42 5000 5008 B-cancer
cell 43 47 5009 5013 I-cancer
carcinoma 48 57 5014 5023 I-cancer
of 58 60 5024 5026 I-cancer
the 61 64 5027 5030 I-cancer
skin 65 69 5031 5035 I-cancer
, 69 70 5035 5036 O
or 71 73 5037 5039 O
in 74 76 5040 5042 O
situ 77 81 5043 5047 B-cancer
cervical 82 90 5048 5056 I-cancer
cancer 91 97 5057 5063 I-cancer
that 98 102 5064 5068 O
has 103 106 5069 5072 O
undergone 107 116 5073 5082 O
potentially 117 128 5083 5094 O
curative 129 137 5095 5103 B-treatment
therapy 138 145 5104 5111 I-treatment

emoglobin 0 9 5112 5121 B-clinical_variable
> 10 11 5122 5123 O
= 11 12 5123 5124 O
9 13 14 5125 5126 B-lower_bound
g 15 16 5127 5128 I-lower_bound
/ 16 17 5128 5129 I-lower_bound
dL 17 19 5129 5131 I-lower_bound
or 20 22 5132 5134 O
> 23 24 5135 5136 O
= 24 25 5136 5137 O
5.6 26 29 5138 5141 B-lower_bound
mmol 30 34 5142 5146 I-lower_bound
/ 34 35 5146 5147 I-lower_bound
L 35 36 5147 5148 I-lower_bound
except 37 43 5149 5155 O
in 44 46 5156 5158 O
cases 47 52 5159 5164 O
of 53 55 5165 5167 O
marrow 56 62 5168 5174 O
infiltration 63 75 5175 5187 O
by 76 78 5188 5190 O
lymphoma 79 87 5191 5199 B-cancer

patients 0 8 5200 5208 O
may 9 12 5209 5212 O
have 13 17 5213 5217 O
de 18 20 5218 5220 B-cancer
novo 21 25 5221 5225 I-cancer
DLBCL 26 31 5226 5231 I-cancer

positron 0 8 5232 5240 B-treatment
emission 9 17 5241 5249 I-treatment
tomography 18 28 5250 5260 I-treatment
( 29 30 5261 5262 I-treatment
PET 30 33 5262 5265 I-treatment
) 33 34 5265 5266 I-treatment

replacement 0 11 5267 5278 B-treatment
therapy 12 19 5279 5286 I-treatment
( 20 21 5287 5288 O
e.g. 21 25 5288 5292 O
, 25 26 5292 5293 O
thyroxine 27 36 5294 5303 B-treatment
, 36 37 5303 5304 O
insulin 38 45 5305 5312 B-treatment
, 45 46 5312 5313 O
or 47 49 5314 5316 O
physiologic 50 61 5317 5328 B-treatment
corticosteroid 62 76 5329 5343 I-treatment
replacement 77 88 5344 5355 I-treatment
therapy 89 96 5356 5363 I-treatment
for 97 100 5364 5367 O
adrenal 101 108 5368 5375 B-chronic_disease
or 109 111 5376 5378 O
pituitary 112 121 5379 5388 B-chronic_disease
insufficiency 122 135 5389 5402 I-chronic_disease
, 135 136 5402 5403 O
etc 137 140 5404 5407 O
. 140 141 5407 5408 O
) 141 142 5408 5409 O
is 143 145 5410 5412 O
not 146 149 5413 5416 O
considered 150 160 5417 5427 O
a 161 162 5428 5429 O
form 163 167 5430 5434 O
of 168 170 5435 5437 O
systemic 171 179 5438 5446 B-treatment
treatment 180 189 5447 5456 I-treatment

s 0 1 5457 5458 O
pregnant 2 10 5459 5467 B-pregnancy
or 11 13 5468 5470 O
breastfeeding 14 27 5471 5484 O
, 27 28 5484 5485 O
or 29 31 5486 5488 O
expecting 32 41 5489 5498 O
to 42 44 5499 5501 O
conceive 45 53 5502 5510 O
or 54 56 5511 5513 O
father 57 63 5514 5520 O
children 64 72 5521 5529 O
within 73 79 5530 5536 O
the 80 83 5537 5540 O
projected 84 93 5541 5550 O
duration 94 102 5551 5559 O
of 103 105 5560 5562 O
the 106 109 5563 5566 O
trial 110 115 5567 5572 O
, 115 116 5572 5573 O
starting 117 125 5574 5582 O
with 126 130 5583 5587 O
the 131 134 5588 5591 O
pre 135 138 5592 5595 O
- 138 139 5595 5596 O
screening 139 148 5596 5605 O
or 149 151 5606 5608 O
screening 152 161 5609 5618 O
visit 162 167 5619 5624 O
through 168 175 5625 5632 O
120 176 179 5633 5636 B-upper_bound
days 180 184 5637 5641 I-upper_bound
after 185 190 5642 5647 I-upper_bound
the 191 194 5648 5651 O
last 195 199 5652 5656 O
dose 200 204 5657 5661 O
of 205 207 5662 5664 O
trial 208 213 5665 5670 B-treatment
treatment 214 223 5671 5680 I-treatment

subjects 0 8 5681 5689 O
must 9 13 5690 5694 O
be 14 16 5695 5697 O
planned 17 24 5698 5705 O
to 25 27 5706 5708 O
receive 28 35 5709 5716 O
full 36 40 5717 5721 O
course 41 47 5722 5728 O
( 48 49 5729 5730 O
6 49 50 5730 5731 O
cycles 51 57 5732 5738 O
) 57 58 5738 5739 O
of 59 61 5740 5742 O
RCHOP 62 67 5743 5748 B-clinical_variable
chemoimmunotherapy 68 86 5749 5767 B-treatment
as 87 89 5768 5770 O
per 90 93 5771 5774 O
clinical 94 102 5775 5783 O
standard 103 111 5784 5792 O
of 112 114 5793 5795 O
care 115 119 5796 5800 O

subjects 0 8 5801 5809 O
of 9 11 5810 5812 O
childbearing 12 24 5813 5825 O
potential 25 34 5826 5835 O
are 35 38 5836 5839 O
those 39 44 5840 5845 O
who 45 48 5846 5849 O
have 49 53 5850 5854 O
not 54 57 5855 5858 O
been 58 62 5859 5863 O
surgically 63 73 5864 5874 O
sterilized 74 84 5875 5885 O
or 85 87 5886 5888 O
have 88 92 5889 5893 O
not 93 96 5894 5897 O
been 97 101 5898 5902 O
free 102 106 5903 5907 O
from 107 111 5908 5912 O
menses 112 118 5913 5919 O
for 119 122 5920 5923 O
> 123 124 5924 5925 O
1 125 126 5926 5927 B-lower_bound
year 127 131 5928 5932 I-lower_bound

